Treatment of central nervous system damage

The invention provides a method of promoting neuronal plasticity in the CNS of a mammal, the method comprising administering to the CNS of the mammal an agent that reduces the inhibitory properties of chondroitin sulphate proteoglycans. Preferred agents are chondroitinases and sulfatases, e.g. chondroitinase ABC. Also provided are methods of identifying further agents.

Patents:
AU 2,009,200,025

Inventor(s): BRADBURY ELIZABETH JANE; MCMAHON STEPHEN BRENDAN; FAWCETT JAMES

Type of Offer: Sale



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent